Read + Share
Amedeo Smart
Independent Medical Education
Lau SCM, Fares AF, Le LW, Mackay KM, et al. Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors. Clin Lung Cancer 2021;22:253-259.PMID: 33582070
Email
LinkedIn
Facebook
Twitter
Privacy Policy